Canaan X L.P., Director, 10% Owner at Protagonist Therapeutics, Inc (PTGX), bought 583,333 shares at $12.00 ($7.0M) on 2016-08-16, disclosed to the SEC on 2016-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| PTGX | SELL | 2018-03-22 | $1.6M | — | Filing → |